Jump to content
Sclero Forums

Search the Community

Showing results for tags 'autoantibodies'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


Location

Found 4 results

  1. Autoantibodies are present before the clinical diagnosis of systemic sclerosis (SSc). Our findings demonstrate that relevant seropositive autoantibodies often precede the clinical diagnosis of Ssc/no scleroderma renal crisis (SRC) and SSc/SRC. PubMed, PLoS One, 2019 Mar 26;14(3):e0214202. (Also see Antibodies) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. Oxidative stress in autoimmune rheumatic diseases. The detection of autoantibodies against specific antigens, might improve both early diagnosis and monitoring of disease activity. PubMed, Free Radic Biol Med, 05/30/2018. (Also see Oxidative Stress) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  3. Identification of a novel autoantibody against self–vimentin specific in secondary Sjögren's syndrome (sSS). This novel autoantibody is highly specific in the diagnosis of sSS, and the underlying molecular mechanism of the disease might be epitope spreading involved with vimentin. PubMed, Arthritis Res Ther, 2018 Feb 12;20(1):30. (Also see Diagnosis of Sjögren's Syndrome) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  4. Elucidation of the potential disease-promoting influence of IgM apoptotic cell–reactive antibodies in lupus. Apoptotic cell-reactive IgM antibodies may be potentially capable of influencing the course of systemic autoimmune disease by affecting both innate and adaptive immunity. Lupus, 01/06/2016. (Also see Autoantibodies) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×
×
  • Create New...